Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma

Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.Materials and Methods The records of 1,095 patients treated with RNU performed at our hospital between 1994...

Full description

Saved in:
Bibliographic Details
Published inCancer research and treatment Vol. 53; no. 3; pp. 795 - 802
Main Authors Ryoo, Hyunsoo, Kim, Jungyu, Kim, Taejin, Kang, Minyong, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Sung, Hyun Hwan
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Cancer Association 01.07.2021
대한암학회
Subjects
Online AccessGet full text
ISSN1598-2998
2005-9256
2005-9256
DOI10.4143/crt.2020.919

Cover

Abstract Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.Materials and Methods The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)–free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).Results The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy–free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.Conclusion Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes.
AbstractList This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.PURPOSEThis study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)-free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).MATERIALS AND METHODSThe records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)-free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy-free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.RESULTSThe mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy-free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes.CONCLUSIONIntramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes.
This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma. The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)-free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS). The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy-free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis. Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes.
Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.Materials and Methods The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)–free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).Results The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy–free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.Conclusion Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes. KCI Citation Count: 0
Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.Materials and Methods The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)–free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).Results The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy–free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.Conclusion Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes.
Author Kim, Taejin
Jeong, Byong Chang
Jeon, Seong Soo
Ryoo, Hyunsoo
Sung, Hyun Hwan
Seo, Seong Il
Lee, Hyun Moo
Kim, Jungyu
Kang, Minyong
Jeon, Hwang Gyun
Author_xml – sequence: 1
  givenname: Hyunsoo
  surname: Ryoo
  fullname: Ryoo, Hyunsoo
– sequence: 2
  givenname: Jungyu
  surname: Kim
  fullname: Kim, Jungyu
– sequence: 3
  givenname: Taejin
  surname: Kim
  fullname: Kim, Taejin
– sequence: 4
  givenname: Minyong
  surname: Kang
  fullname: Kang, Minyong
– sequence: 5
  givenname: Hwang Gyun
  surname: Jeon
  fullname: Jeon, Hwang Gyun
– sequence: 6
  givenname: Byong Chang
  surname: Jeong
  fullname: Jeong, Byong Chang
– sequence: 7
  givenname: Seong Il
  surname: Seo
  fullname: Seo, Seong Il
– sequence: 8
  givenname: Seong Soo
  surname: Jeon
  fullname: Jeon, Seong Soo
– sequence: 9
  givenname: Hyun Moo
  surname: Lee
  fullname: Lee, Hyun Moo
– sequence: 10
  givenname: Hyun Hwan
  surname: Sung
  fullname: Sung, Hyun Hwan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33421984$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738741$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNptkktvEzEURi1URNPCjjXyEqRO8Gsy4w1SiVqoVBEpStaW47ETU8_cweMp6l_gV9dJSgWI1ZXlc8_14ztDJx10FqG3lEwFFfyjiWnKCCNTSeULNGGElIVk5ewETWgp64JJWZ-is2H4TshM8Iq-QqecC0ZlLSbo15Vz1qQBg8NzaPtgk8Wfg24aG_F8dA4vbQv3OmDo8KIzEGDrTV4uxmSgtQO-hhDgp--2eKmbw9Y32-8ijDGrYnZD-4AdRLzu--xcRW0SXkdIOxt8puc6Gt9Bq1-jl06Hwb55qudofX21mn8tbhdfbuaXt4Xhok5FKZqa5ZsRISnhgjd6xpk2jklLialmrjGESKOlIY10ZrOxnBFZu6oURLuN4efow9HbRafujFeg_aFuQd1Fdblc3aj8NoKRKrOfjmw_blrbGNulqIPqo291fDh0_r3T-V323KuaSUorkQXvnwQRfox2SKr1g7Eh6M7COCgmqlldclbv0Xd_znoe8vuzMnBxBEyEYYjWPSOUqH0WVM6C2mdB5SxknP2DG5908rA_qQ__b3oEYaO6og
CitedBy_id crossref_primary_10_1016_j_urolonc_2024_06_001
crossref_primary_10_2340_sju_v59_25973
crossref_primary_10_3389_fonc_2022_948223
crossref_primary_10_3389_fruro_2022_903693
crossref_primary_10_1007_s00345_024_05185_w
crossref_primary_10_3389_fonc_2024_1442168
crossref_primary_10_4143_crt_2023_1219
crossref_primary_10_23736_S2724_6051_23_05448_4
Cites_doi 10.1016/j.urology.2003.12.003
10.1016/j.eururo.2009.12.032
10.1016/j.ijsu.2020.01.016
10.1371/journal.pone.0139976
10.1016/j.juro.2008.10.032
10.1097/01.ju.0000148851.68215.93
10.1016/s0022-5347(17)59324-6
10.1089/end.2006.0374
10.1016/j.eururo.2009.12.001
10.1007/s00345-012-0915-0
10.5489/cuaj.1985
10.1016/j.urolonc.2009.06.003
10.1016/j.eururo.2010.12.042
10.1111/j.1464-410x.2010.09835.x
10.1016/j.eururo.2017.07.036
10.1016/s0022-5347(17)55269-6
10.1002/1097-0142(197611)38
10.1016/s0022-5347(17)55935-2
10.1016/j.urolonc.2013.08.032
10.1016/s0302-2838(01)00002-1
10.1089/end.2006.0306
10.1016/s0022-5347(17)62008-1
10.1089/end.2018.0819
10.1002/cncr.24135
10.1016/j.euf.2018.09.007
10.1016/j.eururo.2012.04.052
10.1016/s0022-5347(05)67019-x
10.1016/j.eururo.2013.03.032
ContentType Journal Article
Copyright Copyright © 2021 by the Korean Cancer Association 2021
Copyright_xml – notice: Copyright © 2021 by the Korean Cancer Association 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.4143/crt.2020.919
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-9256
EndPage 802
ExternalDocumentID oai_kci_go_kr_ARTI_9844207
PMC8291174
33421984
10_4143_crt_2020_919
Genre Journal Article
GroupedDBID ---
29B
5-W
53G
8JR
9ZL
AAYXX
ABDBF
ACUHS
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
F5P
HYE
OK1
RPM
TR2
C1A
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
08R
M~E
ID FETCH-LOGICAL-c348t-54d8215904910343da632acf29e10c76fdc009ca9c0d9fcbbe32098f7540afbc3
ISSN 1598-2998
2005-9256
IngestDate Tue Nov 21 21:35:44 EST 2023
Thu Aug 21 14:32:11 EDT 2025
Fri Jul 11 15:23:07 EDT 2025
Thu Apr 03 06:59:54 EDT 2025
Thu Apr 24 22:54:40 EDT 2025
Tue Jul 01 03:18:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Oncological outcome
Bladder cuff method
Upper tract urothelial carcinoma
Language English
License This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c348t-54d8215904910343da632acf29e10c76fdc009ca9c0d9fcbbe32098f7540afbc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8291174
PMID 33421984
PQID 2476853284
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9844207
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8291174
proquest_miscellaneous_2476853284
pubmed_primary_33421984
crossref_primary_10_4143_crt_2020_919
crossref_citationtrail_10_4143_crt_2020_919
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-07-01
PublicationDateYYYYMMDD 2021-07-01
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Cancer research and treatment
PublicationTitleAlternate Cancer Res Treat
PublicationYear 2021
Publisher Korean Cancer Association
대한암학회
Publisher_xml – name: Korean Cancer Association
– name: 대한암학회
References ref13
ref12
ref15
ref14
ref30
ref11
ref10
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref21
McCarron (ref22) 1983
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
Gupta (ref2) 2008
References_xml – ident: ref18
  doi: 10.1016/j.urology.2003.12.003
– ident: ref12
  doi: 10.1016/j.eururo.2009.12.032
– ident: ref20
  doi: 10.1016/j.ijsu.2020.01.016
– ident: ref28
  doi: 10.1371/journal.pone.0139976
– ident: ref14
  doi: 10.1016/j.juro.2008.10.032
– ident: ref17
  doi: 10.1097/01.ju.0000148851.68215.93
– start-page: 75
  volume-title: Tumors of the renal pelvis and ureter: current concepts and management
  year: 1983
  ident: ref22
– ident: ref27
  doi: 10.1016/s0022-5347(17)59324-6
– ident: ref16
  doi: 10.1089/end.2006.0374
– start-page: 127
  volume-title: Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting
  year: 2008
  ident: ref2
– ident: ref13
  doi: 10.1016/j.eururo.2009.12.001
– ident: ref4
  doi: 10.1007/s00345-012-0915-0
– ident: ref21
  doi: 10.5489/cuaj.1985
– ident: ref6
  doi: 10.1016/j.urolonc.2009.06.003
– ident: ref8
  doi: 10.1016/j.eururo.2010.12.042
– ident: ref10
  doi: 10.1111/j.1464-410x.2010.09835.x
– ident: ref11
  doi: 10.1016/j.eururo.2017.07.036
– ident: ref23
  doi: 10.1016/s0022-5347(17)55269-6
– ident: ref26
  doi: 10.1002/1097-0142(197611)38
– ident: ref24
  doi: 10.1016/s0022-5347(17)55935-2
– ident: ref1
  doi: 10.1016/j.urolonc.2013.08.032
– ident: ref19
  doi: 10.1016/s0302-2838(01)00002-1
– ident: ref15
  doi: 10.1089/end.2006.0306
– ident: ref25
  doi: 10.1016/s0022-5347(17)62008-1
– ident: ref5
  doi: 10.1089/end.2018.0819
– ident: ref29
  doi: 10.1002/cncr.24135
– ident: ref30
  doi: 10.1016/j.euf.2018.09.007
– ident: ref7
  doi: 10.1016/j.eururo.2012.04.052
– ident: ref3
  doi: 10.1016/s0022-5347(05)67019-x
– ident: ref9
  doi: 10.1016/j.eururo.2013.03.032
SSID ssj0064371
Score 2.2609522
Snippet Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for...
This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 795
SubjectTerms Aged
Carcinoma, Transitional Cell - mortality
Carcinoma, Transitional Cell - secondary
Carcinoma, Transitional Cell - surgery
Disease-Free Survival
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Kidney - pathology
Kidney - surgery
Kidney Neoplasms - mortality
Kidney Neoplasms - pathology
Kidney Neoplasms - surgery
Male
Middle Aged
Nephroureterectomy - methods
Original
Retrospective Studies
Ureter - pathology
Ureter - surgery
Ureteral Neoplasms - mortality
Ureteral Neoplasms - pathology
Ureteral Neoplasms - surgery
Urinary Bladder - pathology
Urinary Bladder - surgery
Urinary Bladder Neoplasms - epidemiology
Urinary Bladder Neoplasms - prevention & control
Urinary Bladder Neoplasms - secondary
의학일반
Title Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/33421984
https://www.proquest.com/docview/2476853284
https://pubmed.ncbi.nlm.nih.gov/PMC8291174
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738741
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Cancer Research and Treatment, 2021, 53(3), , pp.795-802
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb5swFLZ6maa9TLsvu8mb5qeIjmCD7UeSJuomtX1ppL4hMLBVbSGiySbtJ-xX7xwwhPQidXtBln1im3wf9jlwzjEhnzmYACLNucOTWDki8X0HzCDfCWB7UrnhmRejoXh4FBzMxbdT_3Rr-0HPa2m1TPbM71vjSv4HVagDXDFK9h-Q7TqFCigDvnAFhOF6L4yna2cMfK4Bgmw4vsC1pBpOVjmmGbksf6K6WQyPC9Otc8erJUwnuxrOgAXlr9oDL24-2BxlCzy5p0IvGXyhf9k4dM4XC-jzBEOqhvMKo7Yu8FX7BE8iKkq7tq8THhgQtmmEmsi5zp-9BZhNxyz0mVZsuo9XJdh0wpRiWq1FQjbW6IoBLaGoC1AjmZ7cIrLPFIeWWlYyJTZEXKb9esQZG9ciOmSh7r_x8Eadd2zDURRXE9s1_LrpGguirdF1IQSx_tKuMd7E3kVW19V5WLXn95dw2Rz62WoDdTz4jY1GgJoJ7DAVuuN67p626_5GPu9r--xGRu9zcxZ9L6PzKgK75WuklRAeJkXY9STogDtkNxzvj2etToFfV5vMv_YemhAOnMWX_hw2lKvtospvs5uuu__29KmTJ-SxNYRo2LD6KdnKimfk4aF19XhO_lhy0zKnLbmpJTdFclNLbloWtEdu2pKbduSmltz0JrkpkJvW5KY1uema3LQj9wsyn01PJgeOPTjEMVyopeOLVIEqq8H6Hblc8DQOuBeb3NPZyDUyyFMDpoWJtXFTnZskybjnapVLMF_iPDH8JdkpyiJ7TaiUoIIHxg10DLp2zhMhskC6qTFeYlKZD8iw_ccjY7Pq4-EuFxFY14hPBPhEiE8E-AwI66QXTTaZO-Q-AXg1Se4my4B8bLGNYE_AD31xkZWrq8gTMgA1HDTPAXnVYN0Nx7kAJQVb5AYLOgEccLOlOPtR551XHmhGUry5z-TekkfrR_cd2VlWq-w9qO_L5IPl9l9CUeP-
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Complete+Bladder+Cuff+Removal+on+Oncological+Outcomes+Following+Radical+Nephroureterectomy+for+Upper+Tract+Urothelial+Carcinoma&rft.jtitle=Cancer+research+and+treatment&rft.au=%EB%A5%98%ED%98%84%EC%88%98&rft.au=%EA%B9%80%EC%A4%80%EA%B7%9C&rft.au=%EA%B9%80%ED%83%9C%EC%A7%84&rft.au=%EA%B0%95%EB%AF%BC%EC%9A%A9&rft.date=2021-07-01&rft.pub=%EB%8C%80%ED%95%9C%EC%95%94%ED%95%99%ED%9A%8C&rft.issn=1598-2998&rft.eissn=2005-9256&rft.spage=795&rft.epage=802&rft_id=info:doi/10.4143%2Fcrt.2020.919&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_9844207
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon